A discovery by the Hellenic Group for the Study of Sepsis in Serious Illness, through research conducted at the Attikon Hospital laboratories, opens up a new window for the treatment of severe pneumonia caused by COVID-19, ANA reports.
The Professor of Pathology-Infectious Diseases at the 4th Department of Pathology at Attikon Hospital, Vangelis Yamarellos, who is also the coordinator of the Hellenic Group for the Study of Sepsis in Serious Illness, speaking exclusively to the Athens-Macedonian News Agency, announced that the group took blood samples from very first Greek patients suffering from pneumonia and severe respiratory failure.
“These blood samples were analyzed at Attikon Hospital, and the Hellenic Group for the Study of Sepsis in Serious Illness discovered the mechanism by which this virus causes the collapse of the immune system, leading to severe pneumonia, where the patient suddenly feels shortness of breath and needs to be intubated,” he said. The research revealed two “target” points, Yamarellos said, explaining that these were molecules circulating in the blood, which, if there could be an intervention to block them using biological agents (monoclonal antibodies), then there would be high hopes of curing the patients.
RELATED TOPICS: Greece, Greek tourism news, Tourism in Greece, Greek islands, Hotels in Greece, Travel to Greece, Greek destinations, Greek travel market, Greek tourism statistics, Greek tourism report
Photo Source: Wikimedia Commons License: CC-BY-SA Copyright: Manu5
